Health and Healthcare

Merck : MRK

All Merck Articles

1096 Articles

Paul Ausick | Jul 2, 2013 at 7:35 AM EDT

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

ThinkstockAlthough Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a…

Jon C. Ogg | Jun 26, 2013 at 11:25 AM EDT

Short Sellers Are Tactical in Top High-Yield Dividend Stocks

Short sellers have really made some big changes in their bets against the key high-yield dividend stocks that had been…

Jon C. Ogg | Jun 12, 2013 at 9:30 AM EDT

Short Sellers Missed the Boat in Top High Dividend Stocks

Short sellers could have cleaned up by betting against the high dividend stocks in May and into June. Investors got…

Jon C. Ogg | Jun 8, 2013 at 7:45 AM EDT

Top Analyst Calls of the Week, Stocks to Buy, Stocks to Sell, Sector by Sector

This last week had much more volatility than what investors have grown used to. 24/7 Wall St. wanted to highlight…

Jon C. Ogg | Jun 6, 2013 at 8:00 AM EDT

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

ThinkstockAs the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum…

Paul Ausick | Jun 3, 2013 at 4:04 PM EDT

Closing Bell for Monday on Wall Street: Markets Wobble, But Finish Higher today

U.S. equity markets opened higher this morning following a slightly upbeat report on eurozone manufacturing PMI. While not yet in…

Jon C. Ogg | May 31, 2013 at 2:22 PM EDT

Rising Interest Rate Risk For Big Dividends, Sector By Sector

The bull market appears to still be alive and well for equities, but the risk of rising interest rates is…

Jon C. Ogg | May 28, 2013 at 10:15 AM EDT

Short Sellers Become Tactical in the Top High-Yield Dividend Stocks

ThinkstockShort sellers are have previously been all over the place when it comes to the high-yield dividend stocks. The May 15…

Jon C. Ogg | May 28, 2013 at 8:00 AM EDT

Top Analyst Upgrades and Stocks to Buy: Eli Lilly, W.R. Grace, Intelsat and More

These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, May 28, 2013.…

Douglas A. McIntyre | May 22, 2013 at 6:52 AM EDT

Media Digest: Reuters, WSJ, NYT, FT, Bloomberg

ThinkstockSony Corp. (NYSE: SNE) cuts forecasts for game console margins for the next several years. (MarketWatch) Sony also cuts targets…

Jon C. Ogg | May 14, 2013 at 7:50 AM EDT

Merrill Lynch Large Cap Pharmaceutical Stocks to Buy

ThinkstockOne of the downsides to a market that seems to go up every day is knowing what stocks to own…

Jon C. Ogg | May 10, 2013 at 12:01 PM EDT

Short Sellers Positions in Top Dividend Stocks

On the surface it looks like short sellers are all over the place in the latest short interest report. The…

Paul Ausick | May 1, 2013 at 4:08 PM EDT

24/7 Wall St. Closing Bell — Wednesday: Markets Cannot Shake-off Low Open and Sink to Close

U.S. equity markets opened lower this morning following a weaker-than-expected employment report from ADP and concern that Friday’s report from…

Jon C. Ogg | May 1, 2013 at 10:45 AM EDT

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

Biotech stocks come and go as far as the flavor of the day for investors. While many of these companies…

Paul Ausick | Apr 30, 2013 at 10:30 AM EDT

Pfizer Earnings Miss Follows Amgen: Is Merck Next?

ThinkstockDrug giant Pfizer Inc. (NYSE: PFE) this morning reported adjusted earnings and revenues that missed analysts estimates, and the stock…

1 … 53 54 55 56 57 … 74

Merck : MRK

All Merck Articles

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

Short Sellers Are Tactical in Top High-Yield Dividend Stocks

Short Sellers Missed the Boat in Top High Dividend Stocks

Top Analyst Calls of the Week, Stocks to Buy, Stocks to Sell, Sector by Sector

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

Closing Bell for Monday on Wall Street: Markets Wobble, But Finish Higher today

Rising Interest Rate Risk For Big Dividends, Sector By Sector

Short Sellers Become Tactical in the Top High-Yield Dividend Stocks

Top Analyst Upgrades and Stocks to Buy: Eli Lilly, W.R. Grace, Intelsat and More

Media Digest: Reuters, WSJ, NYT, FT, Bloomberg

Merrill Lynch Large Cap Pharmaceutical Stocks to Buy

Short Sellers Positions in Top Dividend Stocks

24/7 Wall St. Closing Bell — Wednesday: Markets Cannot Shake-off Low Open and Sink to Close

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

Pfizer Earnings Miss Follows Amgen: Is Merck Next?

“AI Slop or Streaming’s Future? Inside Roku’s Fairground TV Gamble”

With a New iPhone Coming, Here’s What $10,000 in Apple Since the First One Is Worth

I’m Buying Nvidia Ahead of Aug. 26 Earnings Exactly For The Reason You Think

He Suspended Social Security to Add $480 a Month. His Wife’s Check Stopped Too, Raising the Upfront Cost to $108,000.

His $5,000 Employer Disability Check Reduced His Social Security. Six Months Later, It Stopped Counting.

“AI Slop or Streaming’s Future? Inside Roku’s Fairground TV Gamble”

With a New iPhone Coming, Here’s What $10,000 in Apple Since the First One Is Worth

Merck : MRK

All Merck Articles

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

Short Sellers Are Tactical in Top High-Yield Dividend Stocks

Short Sellers Missed the Boat in Top High Dividend Stocks

Top Analyst Calls of the Week, Stocks to Buy, Stocks to Sell, Sector by Sector

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

Closing Bell for Monday on Wall Street: Markets Wobble, But Finish Higher today

Rising Interest Rate Risk For Big Dividends, Sector By Sector

Short Sellers Become Tactical in the Top High-Yield Dividend Stocks

Top Analyst Upgrades and Stocks to Buy: Eli Lilly, W.R. Grace, Intelsat and More

Media Digest: Reuters, WSJ, NYT, FT, Bloomberg

Merrill Lynch Large Cap Pharmaceutical Stocks to Buy

Short Sellers Positions in Top Dividend Stocks

24/7 Wall St. Closing Bell — Wednesday: Markets Cannot Shake-off Low Open and Sink to Close

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

Pfizer Earnings Miss Follows Amgen: Is Merck Next?

“AI Slop or Streaming’s Future? Inside Roku’s Fairground TV Gamble”

With a New iPhone Coming, Here’s What $10,000 in Apple Since the First One Is Worth

I’m Buying Nvidia Ahead of Aug. 26 Earnings Exactly For The Reason You Think

Featured Reads

He Suspended Social Security to Add $480 a Month. His Wife’s Check Stopped Too, Raising the Upfront Cost to $108,000.

His $5,000 Employer Disability Check Reduced His Social Security. Six Months Later, It Stopped Counting.